According to ACMG criteria, the reported variant is classified as pathogenic, and it has been described by Van Coster et al. (2005) (Van Coster et al., 2005) in an individual affected with Aminoacylase-1 deficiency. This evidence concerns the gene ACY1 and hyperinsulinemic hypoglycemia, familial, 4.